Global Cell Therapy Biomanufacturing Market Growth (Status and Outlook) 2026-2032
Description
The global Cell Therapy Biomanufacturing market size is predicted to grow from US$ 10450 million in 2025 to US$ 22690 million in 2032; it is expected to grow at a CAGR of 11.9% from 2026 to 2032.
Cell therapy biomanufacturing is a comprehensive field that involves the use of biotechnology and engineering principles to produce cell therapy products. Cell therapy biomanufacturing refers to the process of producing, processing and optimizing cells as drugs or treatments through a series of complex bioprocesses. These processes include cell isolation, culture, expansion, modification, and final formulation and quality control, aiming to produce safe, effective and therapeutic cell products.
United States market for Cell Therapy Biomanufacturing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cell Therapy Biomanufacturing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cell Therapy Biomanufacturing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cell Therapy Biomanufacturing players cover Biosenic, Bristol-Myers Squibb, Danaher Life Sciences, Iovance Biotherapeutics, Lisata Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Cell Therapy Biomanufacturing Industry Forecast” looks at past sales and reviews total world Cell Therapy Biomanufacturing sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell Therapy Biomanufacturing sales for 2026 through 2032. With Cell Therapy Biomanufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy Biomanufacturing industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy Biomanufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy Biomanufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy Biomanufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy Biomanufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy Biomanufacturing.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy Biomanufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stem Cell
Non-Stem Cell
Segmentation by Application:
Skeletal Muscle Repair
Bone Repair
Cancer
Cardiovascular Diseases
Neurological Disorders
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biosenic
Bristol-Myers Squibb
Danaher Life Sciences
Iovance Biotherapeutics
Lisata Therapeutics
Lonza
Merck KGaA
Thermo Fisher Scientific
Please note: The report will take approximately 2 business days to prepare and deliver.
Cell therapy biomanufacturing is a comprehensive field that involves the use of biotechnology and engineering principles to produce cell therapy products. Cell therapy biomanufacturing refers to the process of producing, processing and optimizing cells as drugs or treatments through a series of complex bioprocesses. These processes include cell isolation, culture, expansion, modification, and final formulation and quality control, aiming to produce safe, effective and therapeutic cell products.
United States market for Cell Therapy Biomanufacturing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cell Therapy Biomanufacturing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cell Therapy Biomanufacturing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cell Therapy Biomanufacturing players cover Biosenic, Bristol-Myers Squibb, Danaher Life Sciences, Iovance Biotherapeutics, Lisata Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Cell Therapy Biomanufacturing Industry Forecast” looks at past sales and reviews total world Cell Therapy Biomanufacturing sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell Therapy Biomanufacturing sales for 2026 through 2032. With Cell Therapy Biomanufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy Biomanufacturing industry.
This Insight Report provides a comprehensive analysis of the global Cell Therapy Biomanufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy Biomanufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Therapy Biomanufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy Biomanufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy Biomanufacturing.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy Biomanufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stem Cell
Non-Stem Cell
Segmentation by Application:
Skeletal Muscle Repair
Bone Repair
Cancer
Cardiovascular Diseases
Neurological Disorders
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biosenic
Bristol-Myers Squibb
Danaher Life Sciences
Iovance Biotherapeutics
Lisata Therapeutics
Lonza
Merck KGaA
Thermo Fisher Scientific
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
92 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Cell Therapy Biomanufacturing Market Size by Player
- 4 Cell Therapy Biomanufacturing by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Cell Therapy Biomanufacturing Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
